Background. Hepatitis D virus (HDV) infection affects 15-20 million individuals worldwide and causes severely progressive hepatitis. It is unknown to what extent cellular immune responses contribute to liver disease and control of viral replication in HDV infection.
Hepatitis D virus (HDV) is a replication defective satellite virus. In humans it can propagate only in the presence of hepatitis B surface antigen and thus only occurs as a coinfection with hepatitis B virus (HBV) [1] . Fifteen million persons worldwide are believed to be infected with HDV. Persistent HDV infection develops in approximately 90% of the HBV carriers superinfected with HDV, leading to the development of early liver cirrhosis and decompensation [2] . To date, the standard anti-HDV therapy with interferon-α (IFN-α) seems to be the only treatment option with limited response rates (<25%) [3] .
HDV is not directly cytopathic and hepatic inflammation, and associated liver injury is likely to be caused by the host immune responses against the virus. Generally, persistent virus infections are often characterized by the presence of hyporesponsive antiviral T cells that are unable to control the infection. Functional recovery of these impaired virus-specific T cells may be achieved by targeting T-cell receptor-mediated signals (signal 1), a costimulatory signal (signal 2) and a cytokine signal (signal 3) that are increasingly recognized to be collectively crucial in the generation, optimal accumulation, and sustained differentiation of pathogen-specific effector T cells [4] .
In specific chronic viral infections such as human immunodeficiency virus, HBV, and hepatitis C virus (HCV), the presence of broad and strong T-cell responses directed against multiple epitopes was required to control viral infection [5] , but T cells regulating HDV infection are not well characterized. Weak HDV-specific T-cell responses were reported in animal models [6] . Nisini and colleagues [7] identified HDV-specific CD4 + T-cell responses in patients with inactive HDV (HDV RNA negative) infection. Very little is known about the specific role of cytotoxic T-lymphocyte response during HDV infection in humans. Work reported by Aslan et al [8] indicated that perforin-positive cytotoxic CD4 + T cells are more frequent in patients with chronic HDV infection than in those with HBV infection alone. Grabowski et al [9] also showed that HDVspecific cytokine responses are detectable in patients with HDV infection and that IFN-γ response was correlated with viral replication. Notwithstanding, a systematic analysis of HDV-specific T-cell responses in a larger cohort of patients have never been systematically analyzed to our knowledge; in particular, the role of coinhibitory molecules or third signal cytokines has not been explored until now. Thus, in the present study we aimed to investigate the proliferative capacity and functionality of HDV-specific CD4 + and CD8 + T cells in patients with chronic HDV infection, using overlapping peptides derived from the entire large HDV antigen. In this cohort, we observed an untimely aging of the total T-cell population, which was associated with an impaired functionality. Importantly, interleukin [IL] 12 supplementation was superior to inhibitory receptor blockade at restoring HDVspecific T-cell responses, partly via the induction of transcription factor T-box expressed in T cells (T-bet).
METHODS

Patient Cohort
In total, 56 patients with persistent HDV infection were included in this study. Baseline characteristics of HDV-infected patients used for the different experiments are shown in Table 1 and Supplementary Table 1 . HDV RNA was detectable in 60%-72% of the patients, and HBV DNA levels were low, with median levels of 1.7-2.4 log IU/mL. Patients were infected with HDV for at least 5-10 years, but the exact time of infection was unknown in most individuals. Liver cirrhosis was present in 22%-50% of patients. HDV genotyping could be performed in 45 patients, and HDV genotype 1 was identified in all but 1 patient, who was infected with genotype 5. Twenty-five HBVmonoinfected patients served as controls for phenotyping. Characteristics of this group are shown in Table 2 . Age, HBV DNA levels, and hepatitis B surface antigen levels did not differ significantly between HDV-infected patients and HBV-monoinfected controls (t test). Alanine aminotransferase levels were significantly higher in HDV-infected patients (t test; P = .002). Eighteen healthy individuals were included as a control group (male-female ratio 9:8 [sex unknown in 1]; median age, 36 years; age range, 25-69 years). The age difference between HDV-infected patients and healthy controls were not significant. Written informed consent was obtained from all patients. Ethics approval was ensured by the local ethics committee of Hannover Medical School.
Monoclonal Antibodies, Phenotyping, Proliferation, and Intracellular Cytokine Staining
Details of fluorochrome-labeled antibodies, phenotyping, proliferation, blocking, and intracellular cytokine staining experiments are provided as supplementary information. Carboxyfluorescein succinimidyl ester proliferation assays were performed as described elsewhere [10] .
Statistical Analysis
Data were recorded as mean values with standard errors of the mean. Phenotyping statistics were determined by using 1-way analysis of variance tests. Further significances were calculated by applying 1-tailed, nonparametric Mann-Whitney U tests to compare independent groups. Correlations were calculated by 1-tailed nonparametric Spearman tests. Statistical analyses were conducted using GraphPad Prism software (GraphPad Software).
RESULTS
Immune Cell Frequencies and Phenotypes in Chronic HDV Infected Patients
Viral infections may be associated with changes in immune cell frequencies and phenotypes [11] . We therefore first performed extensive phenotyping of immune cells ex vivo in a large cohort of persistently HDV-infected patients (n = 49). We observed high interindividual variation in immune cell frequencies. Figure 1B ; P = .02). Because CD57 is associated with replicative senescence and poor response to proliferative stimuli [12] , we examined whether general T-cell functions in HDV-infected patients were altered. Despite high CD57 levels, the overall proliferative and functional capacity of CD8 + and CD4 + T cells with different nonspecific stimuli was not distinct compared with healthy controls ( Figure 1C and 1D ).
HDV Specific T-Cell Proliferative and Functional Responses in Patients With Chronic HDV Infection
As a next step, we studied the proliferative and functional capacities of lymphocytes from HDV-infected patients to respond to HDV peptides. Proliferation was quantified using tritiated thymidine incorporation assays after in vitro stimulation for 5 days in the presence or absence of overlapping peptide pools. Overall, 12 of 46 patients (26%) showed a positive proliferative response to hepatitis delta antigen (HDAg)-derived peptide pools, defined as a stimulation index (SI) of >2 compared with the spontaneous proliferation in the absence of antigen. We also analyzed the breadth and strength of the HDV-specific responses. On an average, only 0.5 HDV peptide pools were recognized of 5 pools in HDV-infected patients, and the mean sum of the SI was only around 1 ( Figure 2A We measured the production of IFN-γ and TNF by intracellular cytokine staining after stimulating peripheral blood mononuclear cells (PBMCs) with HDV peptide pools for 10 days in vitro. Representative fluorescence-activated cell sorting (FACS) plots are depicted in Figure 2B and 2C. The ability to produce both IFN-γ and TNF by HDV-specific CD4 + or CD8 + T cells was evidently reduced in HDV-infected patients ( Figure 2B and 2C). IFN-γ production by CD4 + T cells was slightly elevated above the threshold in 2 of 9 patients (22%), and a positive CD8 + Tcell response was observed in only 2 of 10 (20%) ( Figure 2B ). TNF production was also limited by HDV-specific CD4 + (11%) and CD8 + T cells (20%) in HDV-infected patients (Figure 2C) . The specificity of cytokine responses to HDV peptides was confirmed by stimulating PBMCs from HBV-monoinfected patients, which showed no specific responses for IFN-γ (Supplementary Figure 1 ) and TNF (data not shown). We could not find significant correlations between type of proliferative response and any of the clinical parameters (data not shown). Similarly, cytokine-producing cells did not differ in patients with HDV infection based on RNA status (Supplementary Figure 2A ). Individual alanine aminotransferase levels c Percentages of cirrhosis are based on patients with clinical data within 6 months before or after blood donation: 37, 34, 8, and 9 patients, respectively, in the phenotyping, proliferation, blocking, and functionality experimental groups.
were inversely correlated with the capacity of IFN-γ production by CD8 + T cells on peptide stimulation (Supplementary Figure 2B) .
Restoration of CD4 + and CD8 + T-cell Responses by Targeting Coinhibitory Receptors
In chronic viral infections, weak antigen-specific T-cell responses were shown to be associated with T-cell exhaustion, characterized by the expression of different coinhibitory molecules, of which programmed death 1 (PD-1) and (cytotoxic T-lymphocyte antigen 4) CTLA-4 are prominent [13] . Previous studies have shown that proliferation of antigen-specific T cells can be restored by using neutralizing antibodies to block T-cell exhaustion pathways in patients with chronic HCV or hepatitis E virus infections [14] [15] [16] . Consequently, we blocked PD-1 and CTLA-4 pathways in vitro in 13 HDV-infected patients to determine whether weak proliferation of T lymphocytes in response to specific antigenic stimulation can be restored in HDV-infected patients.
Representative FACS plots and results of the responses of the individual patients are shown in Figure 3A -3D. When blocking coinhibitory pathways, we observed great diversity within HDVspecific T-cell responses among patients and different T-cell subsets. Results are displayed as the mean cumulative response of all HDV pools spanning the entire HDAg. The HDV-specific CD4 + Figure 1 . Frequency and responsiveness of immune cells in hepatitis D virus (HDV)-infected patients: T-cell and regulatory T-cell frequencies and expression of different specific markers were measured directly in vitro in patients with HDV infection and healthy subjects. A, Immune cell frequencies were not altered in patients with HDV infection compared with immunocompetent healthy subjects. B, Expression of CD57 in CD8 + T cells was significantly elevated in HDV-infected patients compared with control groups. C, D, The proliferative capacity of T cells was measured by carboxyfluorescein succinimidyl ester (CFSE) dilution assay after stimulating peripheral blood mononuclear cells from patients with HDV infection and healthy controls for 7 days in the presence of phytohemagglutinin. The functional capacity of T lymphocytes was measured with intracellular cytokine staining after culturing cells from patients with HDV infection and healthy individuals for 10 days with phorbol 12-myristate 13-acetate/ionomycin. The proliferative and functional capacities of T cells were not altered with nonspecific stimuli in HDV-infected patients compared with controls. Statistical analysis was performed with 1-way analysis of variance for independent groups. Abbreviations: HBV, hepatitis B virus; IFN, interferon; PD-1, programmed death 1; TNF, tumor necrosis factor.
T-cell responses were enhanced in 6 of 13 patients (46%) by blocking the PD-1 pathway alone. Not only the response rate but also the breadth and strength of CD4 + T-cell responses was improved significantly by blocking the PD-1 pathway alone.
With blocking of the CTLA-4 pathway alone, only 3 of 13 patients (23%) responded, and no improvement was observed in the breadth and strength of CD4 + T-cell responses. The synergistic effects of simultaneous blockade of PD-1 and CTLA-4 + T cells were nonresponsive to blocking treatment in the majority of patients. Only the breadth of the CD8 + T-cell responses could be regained by blocking either the PD-1 or CTLA-4 pathway or both together. Representative FACS plots are shown for individual patients. Proliferative responses were considered positive when the SI was ≥2. Statistical analysis was performed using 1-tailed, nonparametric Mann-Whitney U tests. Abbreviations: α-CTLA-4, antibody to cytotoxic T-lymphocyte antigen 4; α-PDL-1, antibody to anti-programmed death ligand 1; NS, not significant. signaling on HDV-specific CD4 + T-cell proliferation were observed in only 4 of 13 patients (30.7%), and in 4 other patients (30.7%) counterproductive effects were observed; the positive response attained by blocking the PD-1 pathway alone was diminished by additional blocking of CTLA-4 pathway ( Figure 3B ). Unlike CD4 + , CD8 + T-cell proliferation was improved by blocking the PD-1 pathway in only 2 patients (2 of 13; 15.3%). Surprisingly, none of the patients responded to blockade of the CTLA-4 pathway. Of 2 patients with positive response to PD-1 pathway blockade, 1 displayed synergistic effect with additional blocking of CTLA-4. Of note, 1 patient had the strongest response of CD8 + T cells toward peptide stimulation without additional blocking ( Figure 3D ). Although the response rate and breadth of the CD8 + T-cell response were not augmented, the strength could be restored by blocking inhibitory pathways separately ( Figure 3D ). In summary, CD4 + T cells were more vulnerable to manipulation of PD-1 or CTLA-4, whereas CD8 + T-cell responses were hardly reestablished by blocking T-cell exhaustion pathways in HDV-infected patients.
Effect of the Third Signal Cytokine IL-12 in Rescuing HDV-Specific CD8 + T-Cell Responses
In addition to signal 1 and signal 2, a third signal provided by cytokines can regulate the activation and differentiation of T cells [4] . In persistent HBV and HCV infections, the addition of IL-12 was shown to revive the characteristic exhaustion of antigen-specific T cells [17, 18] . So we intended to study the immune stimulatory effect of IL-12 on HDV-specific T cells in HDV-infected patients. Representative plots are shown in Figure 3) . Although the majority of IFN-γ-producing cells had a central memory phenotype, IFN-γ/TNF-α double-positive cells were mainly effector memory T cells. We also confirmed that findings of intracellular cytokine staining were similar to secretion of cytokines in the culture supernatant (Supplementary Figure 4) .
The Role of the Transcription Factor T-Bet in IL-12 Mediated Restoration of HDV Specific T-Cell Responses
The transcription factor T-bet plays an important role in controlling T-cell immune responses [19] . We investigated whether the improved HDV-specific T-cell responses observed with IL-12 stimulation are associated with T-bet expression in patients with HDV infection. Representative FACS plots are shown in Figure 5A and 5B. The relative expression of T-bet in both CD4
+ and CD8 + HDV-specific T cells was clearly up-regulated in IL-12-stimulated cells, compared with cells stimulated with peptides alone. We did not observe further increases in T-bet expression levels after blocking the PD-1 pathway along with IL-12 stimulation ( Figure 5A and 5B). As depicted in Figure 5C and 5D, we found high IFN-γ production by T-bet-expressing HDV-specific CD4 + or CD8 + T cells after IL-12 treatment. There was no additional improvement in the functionality of T-bet positive T cells with simultaneous blockade of the PD-1 pathway. In summary, the increased cytokine production of HDV-specific T cells in response to IL-12 treatment may be mediated via induction of the transcription factor T-bet.
Parallel Effect of IL-12 on Epstein-Barr Virus and CytomegalovirusSpecific CD8 + T Cells in Patients With HDV Infection
Because the effects of IL-12 stimulation in restoring HDVspecific T cells in vitro were very robust, the next question we aimed to address was whether IL-12 would also increase responses to other antigens and pathogens in patients with HDV infection. We therefore investigated PBMCs from HDV-infected patients for the presence of Epstein-Barr virus (EBV)-and cytomegalovirus (CMV)-specific CD8 + T cells as shown by peptidespecific dextramers and applied identical culture conditions with IL-12 stimulation and the addition of antibodies to anti-programmed death ligand 1. Importantly, proliferation and the cytokine production of CMV-and EBV-specific CD8 + T cells were similarly stimulated by IL-12 (Supplementary Figure 5) .
DISCUSSION
We here present data from a systematic analysis of HDVspecific immune responses on the largest cohort so far of HDV-infected patients investigated for T-cell responses. We demonstrate that (1) the overall frequency and phenotype of immune cells in chronic hepatitis delta show a large interindividual variability but no major differences compared with HBV-monoinfected patients and healthy individuals, (2) HDV infection might be associated with a progressed immune senescence, (3) HDV-specific proliferative and functional responses are rather weak but can be partly restored by blocking the coinhibitory pathways, and (4) the addition of IL-12 markedly improved HDV-specific T-cell responses in vitro via induction of the transcription factor T-bet. However, IL-12 stimulation also affected CMV-and EBV-specific T cells in HDV-infected patients.
Viral infections are frequently associated with distinct changes in the frequency of immune cell subsets [11] . It was therefore surprising that for hepatitis delta patients, we could not find major alterations in the overall frequency of CD4 + , CD8 + , and regulatory T cells. These data are well in line with clinical observations that patients with hepatitis delta do not have opportunistic infections and thus that HDV infection cannot be linked with a general immunodeficiency syndrome [20] . Viral infections are controlled by an effective antiviral T-cell response. Overall, T-cell proliferative responses against HDV were not very frequent and were present in only 26% of subjects, in line with the findings of Nisini and colleagues [7] , who detected proliferation in 27% of their patients. Proliferative impairment can lead to cell senescence, and, accordingly, we noticed significantly higher levels of CD57 expression in CD8 + T cells in HDV-infected patients. In addition to the rather stunted proliferative responses, stimulation with HDV-specific peptides could elicit only paltry amounts of IFN-γ and TNF for both CD4 + and CD8 + HDV-specific T cells in vitro. The inability of HDV-specific CD4 + and CD8 + T cells to produce cytokines can be a main cause of persistent HDV infection, which eventually leads to the development of severe liver disease.
In the present study, we could not link the functional impairment of T-cells in HDV-infected patients to the role of regulatory T cells because their frequencies remained comparable to those in HBV-monoinfected patients and healthy individuals. Interestingly, blockade of PD-1 and/or CTLA-4 (2 key inhibitory receptors that mediate T-cell exhaustion) did not do much to improve the functionality of HDV-specific T cells [14] [15] [16] [21] [22] [23] [24] . In fact, CD4
+ T-cell function was improved in only some patients by PD-1 or CTLA-4 pathway blockade in vitro. Importantly, HDV-specific CD8 + T cells were completely unresponsive to CTLA-4 pathway blockade and regained their proliferative capacity with blockade of the PD-1 pathway in only 2 of 13 patients (15.3%) with HDV infection. Not only the frequency but also the strength of the HDV-specific CD8 + T cells in patients with HDV infection was not improved by targeting coinhibitory pathways. This is well in line with our observation that in vitro PD-1 levels in CD8 + T cells do not significantly vary between the analyzed groups and are therefore unlikely to be the reason for impaired CD8 + T-cell proliferation and function. Interestingly, we did not find a synergistic effect of combined blockade of CTLA-4 and PD-1, in contrast to a previous report in HCV infection [25] but in line with our experience in HCV or hepatitis E virus infection [15, 16] . Generation of effector cytotoxic T cells requires coordination between signal 1 (T-cell receptor/peptide-major histocompatibility complex interaction), signal 2 (costimulatory molecules), and signal 3 (cytokines). In patients with HDV infection, our data indicates that manipulation of signal 1 and 2 pathways to restore weak HDV-specific CD8 + T-cell responses alone is not sufficient. A study by Schurich et al [18] showed that addition of the third signal cytokine (IL-12) restores the functionality of exhausted HBV-specific CD8 + T cells. Another report suggests that activation of T cells by IL-12 or interleukin 18 can contribute to viral clearance in persistent infections [26] . In view of these observations, we investigated the potential of IL-12 to recover the effector functions of T cells in patients with persistent HDV infection. Surprisingly, apart from CD4 + T cells, the more resistant CD8 + T cells also regained their functional capacity in approximately half of the HDV-infected patients studied in 2 independent sets of experiments. The enhanced IFN-γ production mediated by IL-12 was only further marginally increased by simultaneous blockade of PD-1 pathway. In the presence of antigen, activated effector T cells induce production of more IFN-γ whereas memory T cells produce more TNF. Cornberg et al [27] have reported that antigen-specific T cells that can produce only IFN-γ but not TNF are more functionally exhausted. In line with this finding, in our experiments only IFN-γ production was restored by addition of IL-12, not TNF production (data not shown) by HDV-specific T cells. Strikingly, the strength of the HDV-specific CD8 + T cells that produced both IFN-γ and TNF was rescued significantly by the combination of PD-1 pathway blockade plus IL-12 treatment, in line with earlier findings reported in HBV-infected patients [18] . These results suggest that in HDV infection, virus-specific CD8 + T cells were more functionally exhausted and that targeting coinhibitory molecules and the addition of IL-12 may revive their functional capacity. Although the majority of IFN-γ-producing cells had a central memory phenotype, IFN-γ/ TNF-α double-positive cells were mainly effector memory T cells. The naive CD8 + T-cell population was not "hyperactive"
in response to HDV peptides. Based on these results we propose that IL-12 has a major influence in modulating HDV-specific T cells and this can have important implications in the development of the novel immunotherapy for HDV. However, in this context it has to be noted that rescue with blockade of inhibitory pathways, supplemented with IL-12, could be useful for HDV response but dangerous for other specific viruses (EBV, for example), with a risk of specific monoclonal proliferation and induced autoimmune diseases. We also demonstrated in the current study that EBV-and CMV-specific CD8 + T cells drastically increase their effector function in vitro when stimulated with IL-12.
T-bet was shown to have a critical role in regulating virusspecific effector T-cell function by directly repressing the expression of PD-1 and other inhibitory receptors in persistent viral infections [28] . IL-12-mediated induction of T-bet in HBV-and HCV-specific CD8 + T cells was shown to be strongly associated with spontaneous clearance of the virus [17] . We observed elevated T-bet levels in HDV-specific CD4 + and CD8 + T cells with IL-12 stimulation, compared with stimulation by HDV peptides only. We also observed high IFN-γ production in T-bet-positive cells in the presence of IL-12 stimulation, suggesting that IL-12 improves the functionality of HDV-specific T cells via induction of the transcription factor T-bet. Although HDV-specific T-cell functionality was significantly restored by targeting negative regulators of signal 2 and addition of signal 3, we did not find a correlation between immune responses and the HDV RNA status (Supplementary Figure 2A) .
Whether functional restoration of HDV-specific T cells contributes to the control of viral replication needs to be further investigated. To establish such a correlation, many more patients would need to be studied.
Taken together, our data highlight the role of the cellular immune response for the clearance of persistent HDV infection. A combinatorial approach of blocking inhibitory signals and stimulation with cytokines might provide a promising strategy for the treatment of hepatitis delta, the most severe viral infection of the liver, or for the development of a therapeutic vaccine. 
